Patients with Atrial Fibrillation in Clinical Practice: Comorbidity, Drug Treatment and Outcomes (Data from RECVASA Registries)

Aim. To study comorbidity, drug therapy and outcomes in patients with atrial fibrillation (AF) included in the outpatient and hospital RECVASA registries.Material and methods. Patients with AF (n=3169; age 70.9±10.7 years; 43.1% of men) in whom comorbidity, drug therapy, short-term and longterm outc...

وصف كامل

التفاصيل البيبلوغرافية

الحاوية / القاعدة:	Рациональная фармакотерапия в кардиологии
المؤلفون الرئيسيون:	M. M. Loukianov, E. Yu. Andreenko, S. Yu. Martsevich, S. S. Yakushin, A. N. Vorobyev, K. G. Pereverzeva, A. V. Zagrebelnyy, E. Yu. Okshina, V. V. Yakusevich, V. Vl. Yakusevich, E. M. Pozdnyakova, T. A. Gomova, E. E. Fedotova, M. N. Valiakhmetov, V. P. Mikhin, Yu. V. Maslennikova, V. G. Klyashtorny, E. V. Kudryashov, Ju. E. Tatsii, S. A. Boytsov, O. M. Drapkina
التنسيق:	مقال
اللغة:	الإنجليزية
منشور في:	Столичная издательская компания 2020-12-01
الموضوعات:	atrial fibrillation outpatient and hospital registries comorbidity drug treatment prospective monitoring outcomes mortality
الوصول للمادة أونلاين:	https://www.rpcardio.online/jour/article/view/2349